Intra-Cellular Therapies Statistics
Total Valuation
ITCI has a market cap or net worth of $7.90 billion. The enterprise value is $7.44 billion.
| Market Cap | 7.90B |
| Enterprise Value | 7.44B |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, before market open.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ITCI has 105.58 million shares outstanding. The number of shares has increased by 1.83% in one year.
| Shares Outstanding | 105.58M |
| Shares Change (YoY) | +1.83% |
| Shares Change (QoQ) | +0.61% |
| Owned by Insiders (%) | 2.34% |
| Owned by Institutions (%) | 89.48% |
| Float | 103.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.38 |
| Forward PS | 11.03 |
| PB Ratio | 13.18 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 14.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.12, with a Debt / Equity ratio of 0.03.
| Current Ratio | 5.12 |
| Quick Ratio | 4.51 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -18.50% and return on invested capital (ROIC) is -21.42%.
| Return on Equity (ROE) | -18.50% |
| Return on Assets (ROA) | -15.30% |
| Return on Capital (ROIC) | -21.42% |
| Revenue Per Employee | $842,508 |
| Profits Per Employee | -$181,751 |
| Employee Count | 610 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 0.93 |
Taxes
In the past 12 months, ITCI has paid $985,000 in taxes.
| Income Tax | 985,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.75% in the last 52 weeks. The beta is 1.01, so ITCI's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | +18.75% |
| 50-Day Moving Average | 70.03 |
| 200-Day Moving Average | 65.86 |
| Relative Strength Index (RSI) | 55.29 |
| Average Volume (20 Days) | 1,648,857 |
Short Selling Information
The latest short interest is 4.14 million, so 3.92% of the outstanding shares have been sold short.
| Short Interest | 4.14M |
| Short Previous Month | 3.73M |
| Short % of Shares Out | 3.92% |
| Short % of Float | 4.00% |
| Short Ratio (days to cover) | 2.65 |
Income Statement
In the last 12 months, ITCI had revenue of $513.93 million and -$110.87 million in losses. Loss per share was -$1.16.
| Revenue | 513.93M |
| Gross Profit | 477.04M |
| Operating Income | -131.94M |
| Pretax Income | -109.88M |
| Net Income | -110.87M |
| EBITDA | -109.36M |
| EBIT | -109.88M |
| Loss Per Share | -$1.16 |
Balance Sheet
The company has $477.37 million in cash and $16.38 million in debt, giving a net cash position of $461.00 million or $4.37 per share.
| Cash & Cash Equivalents | 477.37M |
| Total Debt | 16.38M |
| Net Cash | 461.00M |
| Net Cash Per Share | $4.37 |
| Equity (Book Value) | 599.50M |
| Book Value Per Share | 5.68 |
| Working Capital | 555.73M |
Cash Flow
In the last 12 months, operating cash flow was -$98.25 million and capital expenditures -$269,000, giving a free cash flow of -$98.52 million.
| Operating Cash Flow | -98.25M |
| Capital Expenditures | -269,000 |
| Free Cash Flow | -98.52M |
| FCF Per Share | -$1.02 |
Margins
Gross margin is 92.82%, with operating and profit margins of -25.67% and -21.57%.
| Gross Margin | 92.82% |
| Operating Margin | -25.67% |
| Pretax Margin | -21.38% |
| Profit Margin | -21.57% |
| EBITDA Margin | -21.28% |
| EBIT Margin | -21.38% |
| FCF Margin | -19.17% |
Dividends & Yields
ITCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.83% |
| Shareholder Yield | -1.83% |
| Earnings Yield | -1.40% |
| FCF Yield | -1.25% |
Analyst Forecast
The average price target for ITCI is $94.83, which is 26.68% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $94.83 |
| Price Target Difference | 26.68% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 40.08% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ITCI has an Altman Z-Score of 30.18 and a Piotroski F-Score of 4.
| Altman Z-Score | 30.18 |
| Piotroski F-Score | 4 |